Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology, with Ph.D. advisor Professor Stuart Schreiber, and then as an independent postdoctoral fellow at the Lewis-Sigler Institute at Princeton University, Ethan Perlstein has developed an approach to studying old drugs and discovering new drugs in model organisms that he calls “evolutionary pharmacology.” Perlstein is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.
Sessions as a Speaker
Lunch @UCSF with Ethan Perlstein – Rare genetic diseases: a new path forward
29 October 2017
12:30 pm – 1:45 pm